Calithera Biosciences, Inc.
(NASDAQ : CALA)

( )
CALA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -1.12%576.632.7%$689.29m
ILMNIllumina, Inc. -0.26%320.443.5%$679.37m
ARRYArray BioPharma Inc. -1.16%38.5014.2%$633.25m
AMGNAmgen, Inc. 0.17%231.101.3%$606.56m
MRNAModerna, Inc. 0.49%71.310.0%$509.30m
GILDGilead Sciences, Inc. -0.03%60.551.0%$504.71m
VRTXVertex Pharmaceuticals, Inc. -2.71%214.541.9%$472.69m
IMMUImmunomedics, Inc. 0.13%87.7211.0%$393.97m
NVAXNovavax, Inc. -3.62%98.3696.5%$322.69m
ALXNAlexion Pharmaceuticals, Inc. 1.84%124.002.0%$302.27m
BIIBBiogen, Inc. -0.61%267.121.6%$255.34m
EXASEXACT Sciences Corp. -3.85%103.0220.7%$234.40m
BNTXBioNTech SE 0.46%94.350.0%$227.84m
SRNESorrento Therapeutics, Inc. -7.54%8.221.4%$194.82m
SGENSeattle Genetics, Inc. -0.10%198.026.0%$173.99m

Company Profile

Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.